Eli Lilly's oral GLP-1 candidate, orforglipron, won't earn approval as fast as the company expected. Meanwhile, a notable ...

Better regulation and enforcement urged before launch of oral treatments, which criminals are likely to try to exploit ...

These trillion-dollar stocks may be setting up for their next move.

Fractyl Health is developing a shot that would program the body to make more of the GLP-1 hormone naturally, a risky bet that it can provide a longer-lasting benefit than blockbuster weight-loss drugs ...